Workplace drug testing used to be a settled area. An employer decided whether to test, picked a panel, and applied the policy uniformly.
That model no longer works. A majority of states have legalized marijuana in some form, a growing number now protect employees from adverse action based on lawful off-duty use, several prohibit testing for non-psychoactive metabolites entirely, and OSHA has constrained blanket post-accident testing. Meanwhile DOT requirements have not changed at all — creating employers who must test some employees under federal mandate while being restricted from testing others in the same building.
There is no federal law requiring or prohibiting drug testing for most private employers.
Two federal frameworks do apply to specific populations:
DOT testing is mandatory for safety-sensitive employees in regulated transportation industries — commercial drivers, pilots, railroad workers, transit employees, pipeline workers, and maritime crews. Requirements are prescriptive and non-negotiable:
Critically: state marijuana protections do not apply to DOT-regulated safety-sensitive positions. Marijuana remains prohibited under federal law for these employees regardless of state legalization, and a state medical marijuana card is not a defense. This is one of the few genuinely clear rules in the area.
The Drug-Free Workplace Act applies to federal contractors above a contract threshold and to federal grantees. It requires a drug-free workplace policy, employee notification, and an awareness program — but it does not require drug testing. Employers routinely misread this as a testing mandate. [VERIFY the current contract threshold.]
Two distinct layers of state regulation.
A number of states impose procedural requirements on employers who choose to test, which can include:
Employers who apply a single national policy without checking these requirements can have a scientifically valid positive result they cannot lawfully act on.
This is the fastest-moving area. Protections come in several forms, and the differences matter:
[VERIFY the complete current list of states and the specific scope of each protection.] See our HR Training by State resources.
Nearly all include exceptions — typically for safety-sensitive positions, federal contractor requirements, DOT-regulated roles, and situations where compliance would cause the employer to lose federal funding or violate federal law. The scope of the safety-sensitive exception varies substantially and is often the operative question.
This is the technical fact that undermines most marijuana testing programs.
Standard urine testing detects THC metabolites, which can remain present for days or weeks after use — long after any impairment has ended. A positive urine test therefore establishes past use, not current impairment.
That distinction is why several states now prohibit adverse action based on metabolite testing specifically. It is also why employers concerned about actual workplace safety are moving toward impairment-based approaches: documented observation by trained supervisors, performance-based assessment, and in some cases saliva testing, which has a shorter detection window more closely aligned with impairment — though it is not a true impairment measure either.
OSHA's anti-retaliation provisions restrict blanket post-accident drug testing, on the reasoning that automatic testing after any injury discourages reporting.
The workable standard: post-accident testing is appropriate where there is a reasonable possibility that employee drug use contributed to the incident, and where the test can actually identify impairment caused by drug use. Testing is generally acceptable when required by state workers' compensation law or by DOT regulation.
Testing that OSHA has treated as problematic includes automatic testing after any reported injury regardless of circumstances, and testing after incidents where drug use could not plausibly have contributed — a bee sting, a repetitive strain injury, an injury caused by another party.
Practical rewrite: replace "any employee involved in a workplace accident will be tested" with a standard requiring an objective basis to believe drug use may have contributed, documented at the time.
Three rules that are frequently confused:
Current illegal drug use is not protected. An employee currently engaging in the illegal use of drugs is not a qualified individual with a disability with respect to that use, and may be held to the same performance and conduct standards as any other employee.
Past addiction is protected. A person with a history of drug addiction who is no longer using, or who is in a supervised rehabilitation program, is protected. Adverse action based on a history of addiction or participation in treatment is a violation.
Alcoholism is a protected disability, though employers may prohibit alcohol use at work and hold employees to the same conduct and performance standards.
Two additional points:
A drug test is not a medical examination under the ADA when it tests only for illegal drug use — which is why pre-employment drug testing is permitted before a conditional offer, unlike medical examinations. Alcohol testing is a medical examination and is subject to the ADA's restrictions.
Lawfully prescribed medication. A positive result explained by a valid prescription is not a basis for adverse action, and the inquiry may implicate the ADA. This is precisely why Medical Review Officer review matters — the MRO contacts the individual, evaluates the explanation, and reports only a verified result. Employers who receive raw laboratory results and act on them are making medical inquiries they are not equipped or entitled to make.
Medical marijuana is the exception that proves the rule: because marijuana remains federally illegal, it is generally not a required ADA accommodation — but several state laws require accommodation of registered patients. See our ADA Compliance Training.
Generally yes, but in a growing number of states you cannot take adverse action based on lawful off-duty use or on a test detecting non-psychoactive metabolites. Exceptions typically apply for safety-sensitive roles, federal contractors, and DOT-regulated positions. Verify the specific state.
No. Marijuana remains prohibited under federal law for DOT safety-sensitive positions regardless of state legalization, and a medical marijuana card is not a defense.
No. It requires covered federal contractors and grantees to maintain a drug-free workplace policy, notify employees, and run an awareness program. It does not mandate testing.
Blanket post-accident testing is restricted under OSHA's anti-retaliation provisions. Test where there is an objective basis to believe drug use may have contributed, or where required by state workers' compensation law or DOT regulation.
Current illegal drug use is not protected. A history of addiction, and participation in or completion of a rehabilitation program, are protected. Alcoholism is a protected disability, though employers may prohibit alcohol use at work and enforce conduct standards.
Standard urine testing detects metabolites that persist long after impairment ends, so a positive establishes past use rather than current impairment. This is why several states restrict adverse action based on metabolite results and why impairment-based approaches are gaining ground.
Tie testing to safety-sensitive roles with documented justification rather than testing universally, build state variations into the policy the way you would for a handbook, require MRO review of every non-negative, and invest in reasonable suspicion training — documented observation is now more defensible than a metabolite result in a growing number of states. Then review it every year, because this is among the fastest-changing areas in employment law.
For structured instruction, explore our Employment Law Training, ADA Compliance Training, and HR Training by State.
Recommended In-Person Seminars